Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1232793.RA5hLnrONxymu4gp8yT65fFf1bAxR12-yyOxni7pijEoc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1232793.RA5hLnrONxymu4gp8yT65fFf1bAxR12-yyOxni7pijEoc130_assertion type Assertion NP1232793.RA5hLnrONxymu4gp8yT65fFf1bAxR12-yyOxni7pijEoc130_head.
- NP1232793.RA5hLnrONxymu4gp8yT65fFf1bAxR12-yyOxni7pijEoc130_assertion description "[Importantly, rapamycin treatment did not affect the expression of AdPLA2 and the production of PGE2 by TSC2-deficient mouse embryonic fibroblast (Tsc2-/-MEFs), rat uterine leiomyoma-derived ELT3 cells, and LAM patient-associated renal angiomyolipoma-derived mesenchymal cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1232793.RA5hLnrONxymu4gp8yT65fFf1bAxR12-yyOxni7pijEoc130_provenance.
- NP1232793.RA5hLnrONxymu4gp8yT65fFf1bAxR12-yyOxni7pijEoc130_assertion evidence source_evidence_literature NP1232793.RA5hLnrONxymu4gp8yT65fFf1bAxR12-yyOxni7pijEoc130_provenance.
- NP1232793.RA5hLnrONxymu4gp8yT65fFf1bAxR12-yyOxni7pijEoc130_assertion SIO_000772 25347447 NP1232793.RA5hLnrONxymu4gp8yT65fFf1bAxR12-yyOxni7pijEoc130_provenance.
- NP1232793.RA5hLnrONxymu4gp8yT65fFf1bAxR12-yyOxni7pijEoc130_assertion wasDerivedFrom befree-2016 NP1232793.RA5hLnrONxymu4gp8yT65fFf1bAxR12-yyOxni7pijEoc130_provenance.
- NP1232793.RA5hLnrONxymu4gp8yT65fFf1bAxR12-yyOxni7pijEoc130_assertion wasGeneratedBy ECO_0000203 NP1232793.RA5hLnrONxymu4gp8yT65fFf1bAxR12-yyOxni7pijEoc130_provenance.